← Evidence map

TrialAntimicrobial agents and chemotherapy2005

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

Mark J DiNubile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 16048928